References
- Proksch E, Jensen JM, Elias PM. Skin lipids and epidermal differentiation in atopic dermatitis. Clin Dermatol. 2003;21:134–144.
- Elias P, Steinhoff M. ‘Outside-to-inside’ (and now back to ‘outside’) pathogenic mechanisms in atopic dermatitis. J Invest Dermatol. 2008;128:1067–1070.
- Kurahashi R, Hatano Y, Katagiri K. IL-4 suppress the recovery of cutaneous permeability barrier function in vivo. J Invest Dermatol. 2008;128:1329–1331.
- Consensus Conference Management of atopic dermatitis in children. Recommendations (short version). Eur J Dermatol. 2005;15:215–223.
- Kao JS, Fluhr JW, Man MQ, Fowler AG, Hachem JP, Crumrine D, Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: Inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol. 2003;120:456–464.
- Eichenfield L, McCollum A, Msika P. The benefits of Sunflower Oleodistillate in pediatric dermatology. Pediatr Dermatol. 2009;26:669–675.
- Msika P, de Belilovsky C, Piccardi N, Chebassier N, Baudouin C, Chadoutaud B. New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement. Pediatr Dermatol. 2008;25:606–612.
- Lewis-Jones MS, Finlay AY, Dykes PJ. The Infants' Dermatitis Quality of Life Index. Br J Dermatol. 2001;144:104–110.
- Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG. The family impact of childhood atopic dermatitis: The Dermatitis Family Impact Questionnaire. Br J Dermatol. 1998;138:107–113.
- Hanifin JM, Hebert AA, Mays SR, Paller AS, Sherertz EF, Wagner AM, Effects of a low-potency corticosteroid lotion plus a moisturizing regimen in the treatment of atopic dermatitis. Curr Ther Res. 1998;59:227–233.
- Lucky AW, Leach AD, Laskarzewski P, Wenck H. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol. 1997;14:321–324.
- Grimalt R, Mengeaud V, Cambazard F. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: A randomized controlled study. Dermatology. 2007;214:61–67.
- Boguniewicz M, Zeichner JA, Eichenfield LF, Hebert AA, Jarrat M, Lucky AW, MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: A multicenter, randomized, vehicle-controlled study. J Pediatr. 2008;152:854–859.
- Patrizi A, Capitanio B, Giacomini F, Sinagra JL, Raone B, Beradesca E. A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIR) in the management of atopic dermatitis in paediatric patients. Pediatr Allergy Immunol. 2008;19:619–625.
- Eberlein B, Eicke C, Reinhardt HW, Ring J. Adjuvant treatment of atopic eczema: Assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol. 2008;22:73–82.
- Kuenzli S, Saurat JH. Peroxisome proliferator-activated receptors in cutaneous biology. Br J Dermatol. 2003;149:229–232.
- Rivier M, Castiel I, Safonova I, Ailhaud G, Michel S. Peroxisome proliferator-activated receptor-alpha enhances lipid metabolism in a skin equivalent model. J Invest Dermatol. 2000;114:681–687.
- Komuves LG, Hanley K, Lefebvre AM, Man MQ, Ng DC, Bikle DD, Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo. J Invest Dermatol. 2000;115:353–360.
- Komuves LG, Hanley K, Man MQ, Elias PM, William ML, Feingold KR. Keratinocyte differentiation in hyperproliferative epidermis: Topical application of PPARalpha activators restores tissue homeostasis. J Invest Dermatol. 2000;115:361–367.
- Staumont-Sallé D, Abboud G, Brénuchon C, Kanda A, Roumier T, Lavogiez C, Peroxisome proliferator-activated receptor α regulates skin inflammation and humoral response in atopic dermatitis. J Allergy Clin Immunol. 2008;121:962–968.
- Hatano Y, Man MQ, Uchida Y, Crumrine D, Mauro TM, Feingold KR, Murine atopic dermatitis responds to peroxisome proliferator-activated receptors α and β/δ (but not γ) and liver X receptors activators. J Allergy Clin Immunol. 2010;125:160–169.
- Cuzzocrea S, Bruscoli S, Mazzon E, Crisafulli C, Donato V, Di Paola R, Peroxisome proliferator-activated receptor-α contributes to the anti-inflammatory activity of glucocorticoids. Mol Pharmacol. 2008;73:323–337.